|
ENZ Enzo Biochem Inc 316253 |
| Balance Sheet |
|
Current Assets
|
59,661,000 |
|
Assets
|
75,291,000 |
|
Current Liabilities
|
23,397,000 |
|
Liabilities
|
27,633,000 |
|
Equity
|
47,658,000 |
|
Shares Out
|
51,458,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-8,990,000 |
|
Investing Cash Flow
|
4,552,000 |
| Market Analysis |
Market Cap
|
57,632,568 |
|
Price
|
0.49 |
|
BVPS
|
0.93 |
|
PB
|
0.53 |
|
EPS
|
0.92 |
|
PE
|
1.22 |
|
PS
|
2.32 |
|
FCF
|
-4,438,000 |
|
| Dividends |
|
| Oct |
Nov |
Dec |
|
|
Ex: 11/15 |
|
|
Pay: 12/2 |
|
| Earnings |
|
| Oct |
Nov |
Dec |
| 10/29 |
|
|
|
12/16 |
-0.07 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENZ documents filed with the SEC.
ENZ Filings
Clear
